Aveanna Healthcare (NASDAQ:AVAH) CAO Sells $59,195.70 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 7,738 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $7.65, for a total transaction of $59,195.70. Following the completion of the sale, the chief accounting officer directly owned 323,884 shares of the company’s stock, valued at approximately $2,477,712.60. This represents a 2.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Deborah Stewart also recently made the following trade(s):

• On Thursday, February 19th, Deborah Stewart sold 11,181 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total value of $80,615.01.
• On Wednesday, February 18th, Deborah Stewart sold 10,896 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.38, for a total value of $80,412.48.
• On Friday, January 2nd, Deborah Stewart sold 11,962 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $93,901.70.
• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total value of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total value of $95,128.44.

Aveanna Healthcare Price Performance

AVAH stock traded up $0.02 during trading hours on Thursday, hitting $7.42. 3,877,110 shares of the stock traded hands, compared to its average volume of 938,081. The stock has a 50-day simple moving average of $8.48 and a 200 day simple moving average of $8.44. The company has a market cap of $1.55 billion, a P/E ratio of 20.61 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39.

Analyst Ratings Changes

A number of research firms recently commented on AVAH. Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. BMO Capital Markets began coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target on the stock. Barclays increased their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research report on Friday, January 16th. UBS Group lifted their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, January 15th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $11.06.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Dynamic Technology Lab Private Ltd raised its holdings in shares of Aveanna Healthcare by 8.9% during the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after purchasing an additional 1,151 shares in the last quarter. Barclays PLC increased its position in Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after buying an additional 1,366 shares during the last quarter. Franklin Resources Inc. raised its holdings in Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after buying an additional 1,528 shares in the last quarter. Intech Investment Management LLC raised its holdings in Aveanna Healthcare by 9.8% during the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after buying an additional 1,739 shares in the last quarter. Finally, Balboa Wealth Partners lifted its position in shares of Aveanna Healthcare by 13.5% in the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock worth $138,000 after buying an additional 2,007 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.